Work

Abstract PS3-04-12: Robust prediction of patients’ response to neoadjuvant therapy across breast cancer subtypes using transcriptomics and histopathology

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-04-12

Authors: T. Cantore, D. Hoang, L. R. Pal, A. Stemmer, S. Dhruba, T. Chang1, S. Sammut, S. Lipkowitz, R. S. Padma1, C. Caldas, N. Ulhas Nair, E. Ruppin

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Institute of Cancer Research, Breast Cancer Now, University of Cambridge, Wellcome/MRC Institute of Metabolic Science

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130687495

Cites:

Cited by:

Related to: